WallStSmart

Abbott Laboratories (ABT)vsTotalEnergies SE ADR (TTE)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

TotalEnergies SE ADR generates 308% more annual revenue ($183.96B vs $45.13B). ABT leads profitability with a 13.9% profit margin vs 8.2%. TTE appears more attractively valued with a PEG of 0.78. TTE earns a higher WallStSmart Score of 73/100 (B).

ABT

Buy

56

out of 100

Grade: C

Growth: 4.0Profit: 6.0Value: 6.0Quality: 4.8
Piotroski: 3/9

TTE

Strong Buy

73

out of 100

Grade: B

Growth: 5.3Profit: 6.5Value: 7.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ABTUndervalued (+0.4%)

Margin of Safety

+0.4%

Fair Value

$87.53

Current Price

$86.30

$1.23 discount

UndervaluedFair: $87.53Overvalued

Intrinsic value data unavailable for TTE.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ABT2 strengths · Avg: 8.5/10
Market CapQuality
$155.82B9/10

Large-cap with strong market position

Price/BookValuation
2.9x8/10

Reasonable price relative to book value

TTE6 strengths · Avg: 8.7/10
Market CapQuality
$206.57B10/10

Mega-cap, among the largest globally

EPS GrowthGrowth
57.1%10/10

Earnings expanding 57.1% YoY

PEG RatioValuation
0.788/10

Growing faster than its price suggests

P/E RatioValuation
13.8x8/10

Attractively priced relative to earnings

Price/BookValuation
1.7x8/10

Reasonable price relative to book value

Operating MarginProfitability
20.3%8/10

Strong operational efficiency at 20.3%

Areas to Watch

ABT3 concerns · Avg: 3.0/10
P/E RatioValuation
25.1x4/10

Moderate valuation

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

EPS GrowthGrowth
-19.7%2/10

Earnings declined 19.7%

TTE2 concerns · Avg: 3.0/10
Revenue GrowthGrowth
3.4%4/10

3.4% revenue growth

Free Cash FlowQuality
$-1.24B2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : ABT

The strongest argument for ABT centers on Market Cap, Price/Book. PEG of 1.33 suggests the stock is reasonably priced for its growth.

Bull Case : TTE

The strongest argument for TTE centers on Market Cap, EPS Growth, PEG Ratio. PEG of 0.78 suggests the stock is reasonably priced for its growth.

Bear Case : ABT

The primary concerns for ABT are P/E Ratio, Piotroski F-Score, EPS Growth.

Bear Case : TTE

The primary concerns for TTE are Revenue Growth, Free Cash Flow.

Key Dynamics to Monitor

ABT carries more volatility with a beta of 0.78 — expect wider price swings.

ABT is growing revenue faster at 7.8% — sustainability is the question.

ABT generates stronger free cash flow (916M), providing more financial flexibility.

Monitor MEDICAL DEVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

TTE scores higher overall (73/100 vs 56/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Abbott Laboratories

HEALTHCARE · MEDICAL DEVICES · USA

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.

Visit Website →

TotalEnergies SE ADR

ENERGY · OIL & GAS INTEGRATED · USA

TotalEnergies SE is a global integrated oil and gas company. The company is headquartered in Paris, France.

Want to dig deeper into these stocks?